๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response

โœ Scribed by T. Pearlstein; E. Spurell; L. A. Hohlstein; V. Gurney; J. Read; C. Fuchs; M. B. Keller

Publisher
Springer Vienna
Year
2003
Tongue
English
Weight
84 KB
Volume
6
Category
Article
ISSN
1434-1816

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Duloxetine in the treatment of binge eat
Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo-controlled trial
โœ Guerdjikova, Anna I. ;McElroy, Susan L. ;Winstanley, Erin L. ;Nelson, Eric B. ;M ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 879 KB

## Abstract ## Objective: This study evaluated duloxetine in the treatment of binge eating disorder (BED) with comorbid current depressive disorders. ## Method: In this 12โ€week, doubleโ€blind, placeboโ€controlled trial, 40 patients with Diagnostic and Statistical Manual of Mental Disordersโ€IVโ€TR B

High-dose escitalopram in the treatment
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial
โœ Anna I. Guerdjikova; Susan L. McElroy; Renu Kotwal; Jeffrey A. Welge; Erik Nelso ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 142 KB ๐Ÿ‘ 1 views

## Abstract ## Objective The purpose of this study was to evaluate the efficacy and safety of highโ€dose escitalopram in the treatment of bingeโ€eating disorder (BED) associated with obesity. ## Method Fortyโ€four outpatients with BED by DSMโ€IV criteria and obesity were randomized to receive either